| Literature DB >> 22514685 |
Alexander Zaborin1, Svetlana Gerdes, Christopher Holbrook, Donald C Liu, Olga Y Zaborina, John C Alverdy.
Abstract
The gut during critical illness represents a complex ecology dominated by the presence of healthcare associated pathogens, nutrient scarce conditions, and compensatory host stress signals. We have previously identified key environmental cues, opioids and phosphate depletion that independently activate the virulence of Pseudomonas aeruginosa. Opioids induce quinolone signal production (PQS), whereas phosphate depletion leads to a triangulated response between MvfR-PQS, pyoverdin, and phosphosensory/phosphoregulatory systems (PstS-PhoB). Yet how P. aeruginosa manages its response to opioids during nutrient scarce conditions when growth is limited and a quorum is unlikely to be achieved is important in the context of pathogenesis in gut during stress. To mimic this environment, we created nutrient poor conditions and exposed P. aeruginosa PAO1 to the specific k-opioid receptor agonist U-50,488. Bacterial cells exposed to the k-opioid expressed a striking increase in virulence- and multi-drug resistance-related genes that correlated to a lethal phenotype in C. elegans killing assays. Under these conditions, HHQ, a precursor of PQS, rather than PQS itself, became the main inducer for pqsABCDE operon expression. P. aeruginosa virulence expression in response to k-opioids required PqsE since ΔPqsE was attenuated in its ability to activate virulence- and efflux pumps-related genes. Extracellular inorganic phosphate completely changed the transcriptional response of PAO1 to the k- opioid preventing pqsABCDE expression, the activation of multiple virulence- and efflux pumps-related genes, and the ability of P. aeruginosa to kill C. elegans. These results indicate that when P. aeruginosa senses resource abundance in the form of phosphate, it overrides its response to compensatory host signals such as opioids to express a virulent and lethal phenotype. These studies confirm a central role for phosphate in P. aeruginosa virulence that might be exploited to design novel anti- virulence strategies.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22514685 PMCID: PMC3325935 DOI: 10.1371/journal.pone.0034883
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1P. aeruginosa PAO1 response to k-opioid during growth in nutrient poor medium.
(A) Effect of 200 µM U-50,488 on PAO1 cell density, n = 3. (B) Pyoverdin production normalized to cell density, n = 3, *p<0.01. (C) Pyocyanin production normalized to cell density, n = 3, *p<0.05. (D–D″) Transmission electron microscopy images of PAO1 cells grown in (D) 0.1xTY, and (D′, D″) grown in 0.1xTY supplemented with 200 µM U-50,488. Flagella (D′) and vesicles (D″) are shown by arrows. (E) Kaplan-Meier survival curves in C. elegans feeding in P. aeruginosa PAO1 grown in poor nutrient medium vs poor nutrient medium containing 50 µM U-50,488. Cell cultures were collected at 7 hrs. Cumulative survival is represented as n = 7/plate, 3 plates/experiment, p<0.01.
Changes in the expression of selected genes in PAO1 in the response to k-opioid U-50,488 during growth in poor nutrient medium.
| PA ID | Gene name | Fold change, +/− opioid | Product name | |
|
| PA1430 |
| −2.2 | Transcriptional regulator LasR |
| PA1432 |
| −2.37 | Autoinducer synthesis protein LasI | |
| PA3476 |
| 1.03 | Autoinducer synthesis protein RhlI | |
| PA3477 |
| −1.24 | Transcriptional regulator RhlR | |
| PA1003 |
| 1.028 | Transcriptional regulator MvfR | |
| PA1000 |
| 2.78 | Quinolone signal response protein | |
|
| PA2512 |
| −19.58 | Anthranilate dioxygenase large subunit |
| PA2513 |
| −35.73 | Anthranilate dioxygenase small subunit | |
| PA2514 |
| −9.87 | Anthranilate dioxygenase reductase | |
|
| PA4209 |
| 7.87 | Probable phenazine-specific methyltransferase |
| PA4217 |
| 13.02 | Flavin-containing monooxygenase | |
| PA4210/PA1899 |
| 26.09 | Probable phenazine biosynthesis protein | |
| PA4211/PA1900 |
| 51.04 | Probable phenazine biosynthesis protein | |
| PA4212/PA1901 |
| 11.59 | Phenazine biosynthesis protein PhzC | |
| PA4213/PA1902 |
| 18.4 | Phenazine biosynthesis protein PhzD | |
| PA4214/PA1903 |
| 23.56 | Phenazine biosynthesis protein PhzE | |
| PA4215/PA1904 |
| 22.23 | Probable phenazine biosynthesis protein | |
| PA4216/PA1905 |
| 18.1 | Probable pyridoxamine 5′-phosphate oxidase | |
|
| PA2193 |
| 24.27 | Hydrogen cyanide synthase HcnA |
| PA2194 |
| 13.03 | Hydrogen cyanide synthase HcnB | |
| PA2195 |
| 14.49 | Hydrogen cyanide synthase HcnC | |
|
| PA3327 | 4.33 | Probable non-ribosomal peptide synthetase | |
| PA3328 | 9.4 | Probable FAD-dependent monooxygenase | ||
| PA3329 | 11.91 | Hypothetical protein | ||
| PA3330 | 11.82 | Probable short chain dehydrogenase | ||
| PA3331 | 16.6 | Cytochrome P450 | ||
| PA3332 | 14.51 | Probable Snoal-like polyketide cyclase | ||
| PA3333 |
| 11.17 | 3-oxoacyl-[acyl-carrier-protein]synthase III | |
| PA3334 | 10.75 | Probable acyl carrier protein | ||
| PA3335 | 4.1 | Putative methyltransferase | ||
| PA3336 | 3.69 | Major facilitator superfamily (MFS) transporter | ||
|
| PA1211 | 2.62 | Hypothetical protein, alpha/beta hydrolase fold | |
| PA1212 | 5.65 | Major facilitator superfamily (MFS) transporter | ||
| PA1213 | 8.92 | Putative monooxygenase/hydrolase | ||
| PA1214 | 8.74 | Putative asparagine synthase | ||
| PA1215 | 9.22 | Acyl-CoA synthetase | ||
| PA1216 | 25.44 | Hypothetical protein | ||
| PA1217 | 16.02 | Probable 2-isopropylmalate synthase | ||
| PA1218 | 12.37 | Putative dioxygenase | ||
| PA1219 | 4.29 | Hypothetical protein | ||
| PA1220 | 4.49 | Hypothetical protein | ||
| PA1221 | 3.56 | Hypothetical protein with AMP-binding domain | ||
|
| PA0105 |
| −6.06 | Cytochrome C oxidase, subunit II |
| PA0106 |
| −3.72 | Cytochrome C oxidase, subunit I | |
| PA0107 | −2.7 | Conserved hypothetical protein | ||
| PA0108 |
| −2.4 | Cytochrome C oxidase, subunit III | |
| PA3928 | −3.59 | Hypothetical protein | ||
| PA3929 |
| −3.23 | Cyanide insensitive terminal oxidase | |
| PA3930 |
| −3.5 | Cyanide insensitive terminal oxidase | |
|
| PA4205 |
| 8.38 | Hypothetical protein |
| PA4206 |
| 4.73 | RND efflux membrane fusion protein precursor | |
| PA4207 |
| 2.7 | RND efflux transporter | |
| PA4208 |
| 3.39 | Probable outer membrane protein precursor | |
| PA4599 |
| 15.2 | RND efflux membrane fusion protein precursor | |
| PA4598 |
| 2.98 | RND efflux transporter | |
| PA4597 |
| 1.85 | Outer membrane protein precursor | |
| PA4067 |
| 4.85 | Outer membrane protein precursor | |
| PA4990 | 7.8 | SMR multidrug efflux transporter | ||
| PA1246 |
| 2.02 | Alkaline protease secretion protein | |
| PA1247 |
| 2.68 | Alkaline protease secretion protein | |
| PA1248 |
| 2.12 | Outer membrane protein precursor | |
| PA1249 |
| 14.66 | Alkaline metalloproteinase precursor | |
| PA1797 | 10.56 | Putative beta-lactamase |
Figure 2Kappa opioid induces activation of pqsABCDE synergistically with HHQ.
Luminescence normalized to cell density was measured dynamically in the reporter strain ΔPqsA/pqsA::luxCDABE grown in 0.1xTY in the presence of (A) varying doses of U-50,488; (B) varying doses of HHQ; (C) varying doses of U-50,488+200 µM HHQ; and (D) varying doses of PQS.
Figure 3QRT-PCR analysis demonstrating involvement of PqsE and PqsH in the response of P. aeruginosa to the k-opioid.
Average values with standard deviations are represented. n = 3/variant, *p<0.05 (wtPAO1 vs ΔPqsE); #p<0.05 (ΔPqsE vs ΔPqsH). Results were reproduced in two independent experiments.
Figure 4Virulence expression in response to k-opioid at high and low phosphate concentrations.
(A) MvfR expression measured by β-galactosidase activity in PAO1/mvfR'-lacZ. (B) pyocyanin production normalized to cell density. (C) pyoverdin production normalized to cell density. (D) Mortality in C. elegans incubated with PAO1 grown in 0.1xTY media plus 200 µM U-50,488 with and without supplementation with Pi. (E–I) Heat maps of gene expression related to (E) low phosphate signaling/acquisition, (F) low iron signaling/acquisition, (G) quorum sensing, (H) multi-drug resistance, and (I) stress response.
Figure 5Proposed circumstances under which P. aeruginosa is exposed to opioids and phosphate depletion during stress and mechanisms of phosphate-dependent virulence activation or suppression.
Critical care treatment destabilizes the indigenous microbiota which becomes replaced by pathogens such as P. aeruginosa that colonize the distal gut. Processed foods or parenteral nutrition leads to nutrient limitation in the distal gut where pathogenesis develops. Physiologic stress, pain, and use of analgesics (opioids) coupled with nutrient limitation, promotes premature activation of the MvfR regulated pqsABCDE operon leading to the expression of multiple virulent and antibiotic resistant genes mediated by PqsE. When phosphate is abundant expression of these genes is suppressed in P. aeruginosa. Mechanisms may include suppression of the PstS-PhoB phosphosensory/phosphoregulatory system that involves phosphate binding to PstS, stabilization of Pst-PhoU-PhoR complex, inability of PhoR to phosphorylate PhoB, and inactivation of the PHO operon including MvfR.